« Previous
Next »
American Journal of Kidney Diseases
Volume 49, Issue 1
, Pages 37-45
, January 2007
The Impact of Reclassifying Moderate CKD as a Coronary Heart Disease Risk Equivalent on the Number of US Adults Recommended Lipid-Lowering Treatment
References
- . USRDS 2005 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2005;
- Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188
- . K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis. 2003;41(suppl 3):S1–S152
- Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13:745–753
- Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41:47–55
- Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285–1295
- Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
- Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307–1315
- Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol. 2006;17:2034–2047
- Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?. Am J Kidney Dis. 1998;32:853–906
- National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
- Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
- . Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239
- Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
- . The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27:645–658
- Centers for Disease Control and Prevention (CDC) and National Center for Health Statistics (NCHS): Third National Health and Nutrition Examination Survey Data. 1997. Hyattsville, MD, US Department of Health and Human Services, CDC. Available at: http://www.cdc.gov/nchs/about/major/nhanes/nh3data.htm. Accessed September 14, 2005
- . Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
- Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920–929
- A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
- . K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 2):S1–S266
- Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–495
- . Cardiovascular risk among US adults with chronic kidney disease, with or without prior myocardial infarction. J Am Coll Cardiol. 2006;48:1183–1189
- . Diabetes and coronary risk equivalency: What does it mean?. Diabetes Care. 2006;29:457–460
- Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–234
- Should diabetes be considered a coronary heart disease risk equivalent?. Results from 25 years of follow-up in the Renfrew and Paisley survey (Diabetes Care). 2005;28:1588–1593
- Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients (The Heart Outcomes Prevention Evaluation Study Investigators). N Engl J Med. 2000;342:145–153
- Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000;102:1014–1019
- Diabetes as a risk factor for myocardial infarction: Population and gender perspectives. J Intern Med. 1997;241:485–492
- Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease. Diabetes Care. 1993;16:708–713
- Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001;161:242–247
- The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 Years of follow-up. Arch Intern Med. 2001;161:1717–1723
- . Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care. 1979;2:120–126
- Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44:198–206
- . Managing dyslipidemia in chronic kidney disease. J Gen Intern Med. 2004;19:1045–1052
- . Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int. 2001;59:260–269
- Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation. 2004;110:1557–1563
- Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–248
- . Study of Heart and Renal Protection (SHARP). Kidney Int Suppl. 2003;84:S207–S210
Originally published online as doi:10.1053/j.ajkd.2006.09.017 on December 1, 2006.Support: None. Potential conflicts of interest: None.
PII: S0272-6386(06)01514-9
doi: 10.1053/j.ajkd.2006.09.017
© 2006 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 49, Issue 1
, Pages 37-45
, January 2007
